Aster DM Healthcare Limited — Investor Meet, 08-05-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Aster DM Healthcare's Q4 FY26 earnings call highlighted strong performance. The combined proforma (Aster + Quality Care) saw Q4 revenue up 18% to INR 2,361 Cr and Operating EBITDA up 25% to INR 517 Cr, boosting margins to 21.9%. Aster India standalone grew Q4 revenue by 17% and Operating EBITDA by 31%. QCIL also posted robust 18% Q4 revenue and 23% EBITDA growth. The merger secured shareholder approval and awaits final NCLT clearance. Management is confident about continued growth driven by capacity expansion, a shift to higher-acuity care, and synergies post-merger, with over 15,000 beds planned.